169 related articles for article (PubMed ID: 27803799)
1. Approach to patients with refractory coeliac disease.
Nasr I; Nasr I; Campling H; Ciclitira PJ
F1000Res; 2016; 5():. PubMed ID: 27803799
[TBL] [Abstract][Full Text] [Related]
2. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.
Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ
Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478
[TBL] [Abstract][Full Text] [Related]
3. Monitoring nonresponsive patients who have celiac disease.
Krauss N; Schuppan D
Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
[TBL] [Abstract][Full Text] [Related]
4. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
[TBL] [Abstract][Full Text] [Related]
5. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in refractory coeliac disease: a review.
Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P
Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
[TBL] [Abstract][Full Text] [Related]
8. Azathioprine and prednisone combination therapy in refractory coeliac disease.
Goerres MS; Meijer JW; Wahab PJ; Kerckhaert JA; Groenen PJ; Van Krieken JH; Mulder CJ
Aliment Pharmacol Ther; 2003 Sep; 18(5):487-94. PubMed ID: 12950421
[TBL] [Abstract][Full Text] [Related]
9. T-cell repertoires in refractory coeliac disease.
Ritter J; Zimmermann K; Jöhrens K; Mende S; Seegebarth A; Siegmund B; Hennig S; Todorova K; Rosenwald A; Daum S; Hummel M; Schumann M
Gut; 2018 Apr; 67(4):644-653. PubMed ID: 28188172
[TBL] [Abstract][Full Text] [Related]
10. Refractory coeliac disease.
Daum S; Cellier C; Mulder CJ
Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
[TBL] [Abstract][Full Text] [Related]
11. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue.
Daum S; Weiss D; Hummel M; Ullrich R; Heise W; Stein H; Riecken EO; Foss HD;
Gut; 2001 Dec; 49(6):804-12. PubMed ID: 11709515
[TBL] [Abstract][Full Text] [Related]
12. The management of refractory coeliac disease.
Woodward J
Ther Adv Chronic Dis; 2013 Mar; 4(2):77-90. PubMed ID: 23556127
[TBL] [Abstract][Full Text] [Related]
13. Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges.
Scarmozzino F; Pizzi M; Pelizzaro F; Angerilli V; Dei Tos AP; Piazza F; Savarino EV; Zingone F; Fassan M
Front Oncol; 2023; 13():1273305. PubMed ID: 38023263
[TBL] [Abstract][Full Text] [Related]
14. Classification and management of refractory coeliac disease.
Rubio-Tapia A; Murray JA
Gut; 2010 Apr; 59(4):547-57. PubMed ID: 20332526
[TBL] [Abstract][Full Text] [Related]
15. Novel variant of EATL evolving from mucosal γδ-T-cells in a patient with type I RCD.
van Wanrooij RL; de Jong D; Langerak AW; Ylstra B; van Essen HF; Heideman DA; Bontkes HJ; Mulder CJ; Bouma G
BMJ Open Gastroenterol; 2015; 2(1):e000026. PubMed ID: 26462278
[TBL] [Abstract][Full Text] [Related]
16. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
[TBL] [Abstract][Full Text] [Related]
17. [Jejunal ulcerations - a diagnostic challenge in a patient with coeliac disease].
Weber M; Schumann M; Felber J; Mireskandari M; Schmidt C; Stallmach A
Z Gastroenterol; 2015 Nov; 53(11):1261-6. PubMed ID: 26562400
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Schmitz F; Tjon JM; van Bergen J; Koning F
Mol Immunol; 2014 Mar; 58(1):10-6. PubMed ID: 24252355
[TBL] [Abstract][Full Text] [Related]
19. Decreased circulating iNKT cell numbers in refractory coeliac disease.
Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
[TBL] [Abstract][Full Text] [Related]
20. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
